All metabolite identifications were assigned as putative (MSI Level 2), in accordance with the Metabolomics Standards Initiative (Sumner et al., 2007), as authentic standards were not analyzed under matched chromatographic and instrumental conditions
Phase 2 trial - Lancet, 2023 Receptor systems the peptide acts on - GLP-1, GIP and glucagon - which is why it's studied as a 'triple agonist'
Most peptides remain stable at 2, 8 C for 28 to 30 days after reconstitution
These are standard practices for all peptide users, but the consequences of contamination are more severe for autoimmune patients
doi: 10.1126/scitranslmed.abi4632 149 TurnerBCreeBACKapposLMontalbanXPapeixCWolinskyJSet al
We're seeing more and more studies leverage this prolonged effect to understand long-term metabolic adaptations, a demanding, often moving-target objective in this field